BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25735642)

  • 1. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.
    Baer AN; McAdams DeMarco M; Shiboski SC; Lam MY; Challacombe S; Daniels TE; Dong Y; Greenspan JS; Kirkham BW; Lanfranchi HE; Schiødt M; Srinivasan M; Umehara H; Vivino FB; Vollenweider CF; Zhao Y; Criswell LA; Shiboski CH;
    Ann Rheum Dis; 2015 Aug; 74(8):1557-61. PubMed ID: 25735642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
    Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro(SSA) and anti-La(SSB) antibodies in lupus erythematosus and Sjögren's syndrome.
    Provost TT
    Keio J Med; 1991 Jun; 40(2):72-7. PubMed ID: 1881026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
    Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome.
    Kim BE; Kwon JS; Choi JH; Park PG; Ahn HJ
    J Oral Pathol Med; 2023 Feb; 52(2):188-194. PubMed ID: 36183157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    Ben-Eli H; Solomon A; Aframian DJ; Ben-Chetrit E; Mevorach D; Kleinstern G; Waterboer T; Willhauck-Fleckenstein M; Pawlita M; Paltiel O
    PLoS One; 2020; 15(12):e0244712. PubMed ID: 33382786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome: data from a nationwide cohort for Sjögren's syndrome in Korea.
    Park Y; Lee J; Koh JH; Sung YK; Lee SS; Choe JY; Shim SC; Kim JM; Kwon SR; Kim HO; Chung SH; Park SH; Kwok SK
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):107-113. PubMed ID: 31376264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.
    Ben-Chetrit E; Fischel R; Rubinow A
    Clin Rheumatol; 1993 Dec; 12(4):471-4. PubMed ID: 8124907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.